CRCs, CRAs, CTMs Have It Tough; The IRB/IEC Revolution; and More
Clinical Leader
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
Welcome to the Clinical Trial Insights newsletter, featuring strategic insights and expert opinions on designing and running clinical trials. Each edition covers the latest trending articles on ClinicalLeader.com.
In this week's issue, we'll hear how difficult it can be working as a CRC, CRA, or CTM in today's industry from a seasoned professional, how EDCs can better serve DCTs, what differs between IECs and IRBs, ways to improve trial accessibility for disabled patients, and other popular insights.
If you like what you're seeing in our condensed LinkedIn editions, subscribe to our daily newsletter for full access to exclusive articles, webinars, e-books, and more! Subscribe Now →
TOP 5 READS OF THE PAST WEEK
With 20+ years as a CRC, CRA, clinical trial manager, and project manager, Tiffany Ashton, MAS, CCRA sat down with Clinical Leader Chief Editor Dan Schell to discuss how difficult it can be working in some of these roles in today’s clinical trials industry.
Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology? Ultimately, given their market dominance, legacy EDC providers are likely to decide the answer.
Are Institutional Review Boards (IRBs) and Independent Ethics Committees (IECs) the same? And if they're not, how are they different? Kamila A. Novak of KAN Consulting MON. I.K.E. helps define the two bodies and their roles across the globe, as well as explains how we might rethink their roles in the future.
Lowering barriers to participation could boost the diversity of patients in clinical trials. PCM TRIALS - Quality Mobile Research shows us how to analyze gender, race, and ethnicity data to understand the differences that mobile visits from a certified mobile research nurse can make.
Recommended by LinkedIn
While increasing DE&I in clinical trials is essential to all individuals, this article speaks to considerations for removing barriers and improving trial accessibility for individuals with disabilities. The discussion includes combating stigma and bias, changing structural design, and more.
MORE TO EXPLORE
Join Our Next Clinical Leader Live Event!
December 18th @ 2PM EST
Why isn't more tech being used in clinical trials? Join our next Clinical Leader Live event for a discussion on some possible reasons for this conundrum and what technologies are helping and increasing in adoption.
Clinical Leader is an online community serving professionals in the clinical research space. We share insights and best practices — from industry experts — to help sponsors and CROs tackle the biggest challenges they face in designing and running clinical trials.
To get the most out of our offerings, join the Clinical Leader community.